Getting older often comes with a frustrating change: the energy that once seemed endless becomes harder to maintain. Now, scientists investigating the aging process have identified a potential reason hidden deep inside our cells, and their experiments suggest that part of this decline could be reversible. The discovery focuses on mitochondria, the tiny structures responsible for producing much of the energy our cells need to function, and a substance that helps them maintain their flexibility as we age.
Researchers led by scientists at the Leibniz Institute on Aging in Germany found evidence linking declining levels of a membrane lipid called phosphatidylcholine to changes in mitochondrial function. In experiments involving roundworms, restoring this substance helped mitochondria behave more like those of younger organisms within just a few days. The findings, published in Nature Communications, raise intriguing questions about whether the same biological mechanism could eventually be targeted in humans, although the research has not demonstrated that aging can be reversed in people.
Scientists Link Cellular Aging to a Declining Lipid
The human body contains an estimated 37 trillion cells, and many depend on mitochondria to produce the energy needed to function. These tiny structures convert energy from food into a form cells can use, earning them the familiar nickname of the powerhouses of the cell. However, their role involves more than simply generating energy. Mitochondria must also maintain their structure and flexibility so they can respond to changing demands inside the body, and researchers are increasingly investigating how changes in these processes contribute to aging.
The team led by the Leibniz Institute on Aging examined whether changes in the cellular environment could help explain why mitochondrial performance deteriorates over time. Their findings pointed toward phosphatidylcholine, a lipid that helps maintain mitochondrial membrane properties and supports the formation of flexible networks. As levels of this substance decline, mitochondria may become less capable of reorganizing themselves efficiently, potentially affecting how energy is distributed throughout a cell. The researchers’ findings suggest that this change could be one part of the wider biological process associated with aging.
Maria Ermolaeva, the study’s lead author, compared the process to an electricity network whose connections gradually become damaged. “You can imagine the whole system as a finely branched power grid that becomes increasingly damaged with age: connections break down and currents stall,” Ermolaeva said in a press statement. She explained that energy production can continue even when the system becomes less efficient and sustainable. This distinction offers a possible explanation for why mitochondrial decline involves more than the amount of energy produced, although the study does not establish phosphatidylcholine as the sole cause of age-related fatigue.
Why Your Cells Depend on Flexible Mitochondria
Mitochondria are often compared to tiny batteries, but they are dynamic structures that continually respond to their surroundings. Their organization can change as cells experience different demands, and maintaining that flexibility helps them function efficiently. When mitochondrial networks become less adaptable, cells may struggle to distribute energy as effectively as before. Researchers are therefore examining whether changes in mitochondrial structure and membrane composition contribute to the decline in cellular performance associated with aging.
What Phosphatidylcholine Actually Does
Phosphatidylcholine is a lipid that forms part of cellular membranes, helping create the structures that allow cells and their internal components to function. Within mitochondria, membrane properties influence the organization and behavior of these energy-producing structures. The researchers linked declining phosphatidylcholine levels with reduced mitochondrial flexibility, suggesting that maintaining appropriate levels of this lipid may help preserve cellular function. However, the findings do not mean that increasing phosphatidylcholine through supplements will automatically restore youthful energy or slow aging in humans. Establishing whether such an approach could work safely in people will require additional research.
How Researchers Tracked the Aging Process
Studying aging requires scientists to observe biological changes over time and determine how different processes relate to one another. To investigate phosphatidylcholine’s role, Ermolaeva and her colleagues combined experiments involving human cells and clinical datasets with detailed studies of Caenorhabditis elegans, a small roundworm widely used in aging research. The animal has a lifespan of approximately two to three weeks, allowing scientists to observe changes across its life relatively quickly. Its fully mapped cellular lineage also gives researchers a detailed framework for examining how individual cells develop and change as the organism ages.
By combining these approaches, the team connected patterns observed in laboratory models with human-based data. Direct observations of the roundworms allowed researchers to track molecular changes as they occurred, helping them examine the sequence of events associated with mitochondrial decline. The study indicated that the process unfolds in stages, beginning with changes involving stress resistance, followed by metabolic changes and eventually epigenetic changes. Epigenetics concerns the processes that regulate how genes are switched on or off without necessarily changing the underlying DNA sequence, making it an important area of research into how cells change over time.
The researchers also identified sex-specific differences in the aging patterns they examined. Their findings suggest that mitochondrial aging may be connected to broader changes in cellular regulation rather than a single isolated event. Understanding the order in which these changes occur could help scientists investigate when particular biological processes begin and whether they can be modified. The research provides a framework for further investigation, although it does not establish that every stage can be reversed or that modifying one process would reverse aging throughout the body.
Researchers Found a Possible Reversal in Worms
The most striking part of the study came when researchers investigated whether the mitochondrial changes could be modified. According to the findings, feeding roundworms either choline or phosphatidylcholine resulted in younger-acting mitochondria within just a few days. This suggests that at least some aspects of the mitochondrial changes observed in these animals were reversible under the experimental conditions. Rather than simply documenting deterioration, the researchers identified a potential way to influence a process associated with aging, opening another avenue for future studies.
Ermolaeva described the broader implications of the research in a press statement. “Our work shows that both mitochondrial aging and broader systemic aging are, at least in part, modifiable,” she said. “If we understand the underlying processes, we may be able to take targeted countermeasures.” Her comments reflect the potential significance of identifying mechanisms that can be modified, but the distinction between laboratory findings and human treatments remains essential. The experiments demonstrated a response in roundworms, while the human-based findings helped researchers connect the proposed mechanism with biological patterns relevant to people.
The results do not establish a treatment that reverses a person’s biological age, restores youthful stamina or prevents age-related diseases. Scientists still need to determine whether the same mechanism can be targeted safely in humans and whether doing so produces meaningful benefits beyond laboratory measurements. Nevertheless, the worm experiments offer a specific research direction by suggesting that mitochondrial aging may involve processes that are more adaptable than previously assumed. Further studies will be needed to establish how much of this mechanism can be modified and whether those changes translate into improved health.
The Menopause Finding Adds Another Dimension
One detail in the research could be particularly relevant to scientists investigating age-related changes in energy levels. The team found that phosphatidylcholine levels in humans dropped rapidly around the age of menopause, a period often associated with increased fatigue. This observation raises questions about whether changes in the lipid could be connected to some of the biological processes occurring during this stage of life. However, the finding does not prove that declining phosphatidylcholine causes menopausal fatigue, and it does not establish that restoring the substance would relieve symptoms.
Why Sex-Specific Differences Matter
The researchers’ observations of sex-specific differences provide another reason to examine the biological processes involved more closely. Aging does not necessarily follow identical patterns across every individual, and differences in how cellular changes develop may help scientists identify factors that influence those patterns. The menopause-related finding offers a potential lead for further research into phosphatidylcholine levels and mitochondrial function during this period. For now, it remains an observation that requires additional investigation rather than evidence of a new treatment for fatigue or other menopause-related symptoms.
What This Discovery Does and Does Not Prove
The possibility of modifying cellular aging has attracted attention because it could help researchers understand why biological function declines over time. However, the study’s findings need to be distinguished from broader claims about reversing human aging. The research offers evidence of a potential mechanism and a response in worms, but it does not demonstrate that the same intervention will produce equivalent results in people.
The main findings include:
- A potential mechanism: Declining phosphatidylcholine levels were linked to reduced mitochondrial flexibility during aging.
- A staged process: Researchers observed changes involving stress resistance, metabolism and epigenetic regulation.
- A response in worms: Feeding choline or phosphatidylcholine to roundworms produced younger-acting mitochondria within days.
- Human-based evidence: Experiments involving human cells and clinical datasets helped connect the laboratory findings with patterns relevant to people.
- Questions for future research: Scientists still need to determine whether targeting this mechanism can safely improve mitochondrial function in humans.
These findings provide a foundation for further investigation, but results in a short-lived laboratory organism cannot guarantee the same effects in humans. The supplied research also does not establish that taking choline or phosphatidylcholine supplements can reverse aging, restore youthful energy or prevent age-related disease. Those possibilities would require carefully designed studies to determine whether an intervention works, how it should be used and whether it offers meaningful benefits without unacceptable risks.
The Next Step Is Finding Out Whether Humans Can Benefit
The research gives scientists a more specific target for studying the relationship between mitochondrial function and aging. By investigating how membrane composition affects mitochondrial flexibility, researchers can examine whether the loss of cellular efficiency is connected to processes that might be modified. Future studies will need to clarify what drives phosphatidylcholine levels to decline, how the mechanism operates across different stages of life and whether changing it can improve cellular function in humans. They will also need to determine whether any benefits extend beyond laboratory measurements to outcomes that matter for people’s health.
For now, the strongest finding is that researchers modified a feature of mitochondrial aging in roundworms by providing choline or phosphatidylcholine. The work does not yet offer a proven way to reverse human aging, but it identifies a biological process that scientists can investigate further. If subsequent research establishes that the same mechanism can be safely targeted in people, phosphatidylcholine could become part of a broader effort to understand and potentially modify some of the cellular changes that accompany getting older.
Sources:
Poliezhaieva, T., Li, Y., Chaudhari, P. S., Isildak, U., Alonso-Pernas, P., Valentim, I. S., Su, F., Espada, L., Bayar, M., Fu, L., Koeberle, A., Dönertaş, H. M., & Ermolaeva, M. A. (2026). Aging-associated decline of phosphatidylcholine synthesis is a malleable trigger of natural mitochondrial aging. Nature Communications, 17(1). https://doi.org/10.1038/s41467-026-71508-7
